An accessory slip of the fibularis tertius to the extensor digitorum longus - an unreported variant.

The fibularis tertius (FT) is one of three muscles which constitute the anterior compartment of the leg. The anatomical variants of this muscle usually pertain to its origins, number of final tendons or points and shapes of insertions. In this case, it had an additional slip (AS) which originated from the same area as the main muscle belly and after descending along the extensor digitorum longus (EDL) it fused with one of its main tendons.

Rare variant of psoas minor or a newly observed component of the iliopsoas muscle complex? Case report.

Background: Multiple structures found in different compartments of the human body are considered as morphologically variable, however, this general assumption does not apply to the components of the iliopsoas muscle complex. In this study, we report a case of an extremely variable muscle observed in the above-mentioned compartment.

Materials And Methods: During a routine dissection of the posterior abdominal wall of a 78-year-old male cadaver, an anomalous muscle with an atypical morphology was observed, photographed and subjected to further measurements.

The accessory renal arteries: A systematic review with meta-analysis.

The accessory renal arteries (ARAs) are a well-described variant of the renal vasculature with clinical implications for radiologists, surgeons, and clinicians. The aim of the present systematic review with meta-analysis was to estimate the pooled prevalence of ARAs, including their variant number, origin, and termination, and to highlight symmetrical and asymmetrical morphological patterns. The systematic review used four online databases in accordance with PRISMA 2020 and Evidence-based Anatomy Workgroup guidelines.

Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC.

Over the course of nearly six decades since the inception of initial trials involving 5-FU in the treatment of mCRC (metastatic colorectal cancer), our progressive comprehension of the pathophysiology, genetics, and surgical techniques related to mCRC has paved the way for the introduction of novel therapeutic modalities. These advancements not only have augmented the overall survival but have also positively impacted the quality of life (QoL) for affected individuals. Despite the remarkable progress made in the last two decades in the development of chemotherapy, immunotherapy, and target therapies, mCRC remains an incurable disease, with a 5-year survival rate of 14%.